12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Deals

GlaxoSmithKline, Prestige Brands Holdings deal

GlaxoSmithKline will divest its non-core consumer healthcare OTC products to Prestige for £426 million ($665.5 million) in cash. The brands...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >